BNP Paribas Financial Markets’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $92.3M | Sell |
257,112
-56,482
| -18% | -$17.3M | 0.03% | 479 |
|
|
2026
Q1 | $78.6M | Buy |
313,594
+100,261
| +47% | +$24.9M | 0.04% | 480 |
|
|
2025
Q4 | $58.7M | Buy |
213,333
+92,033
| +76% | +$25.2M | 0.03% | 608 |
|
|
2025
Q3 | $31.8M | Sell |
121,300
-243,876
| -67% | -$59.3M | 0.02% | 847 |
|
|
2025
Q2 | $79.9M | Buy |
365,176
+122,265
| +50% | +$26.1M | 0.05% | 403 |
|
|
2025
Q1 | $54.4M | Buy |
242,911
+67,012
| +38% | +$18.5M | 0.03% | 562 |
|
|
2024
Q4 | $57.6M | Buy |
175,899
+41,416
| +31% | +$13M | 0.03% | 558 |
|
|
2024
Q3 | $40.4M | Buy |
134,483
+63,102
| +88% | +$19.3M | 0.03% | 577 |
|
|
2024
Q2 | $23.5M | Buy |
71,381
+8,258
| +13% | +$2.92M | 0.02% | 698 |
|
|
2024
Q1 | $25M | Sell |
63,123
-7,573
| -11% | -$2.8M | 0.02% | 664 |
|
|
2023
Q4 | $24.9M | Buy |
70,696
+56,465
| +397% | +$20M | 0.03% | 604 |
|
|
2023
Q3 | $5.34M | Sell |
14,231
-9,461
| -40% | -$3.66M | 0.01% | 1225 |
|
|
2023
Q2 | $9.06M | Sell |
23,692
-1,244
| -5% | -$444K | 0.01% | 957 |
|
|
2023
Q1 | $8.64M | Sell |
24,936
-105,019
| -81% | -$30.7M | 0.01% | 977 |
|
|
2022
Q4 | $30.6M | Buy |
129,955
+69,030
| +113% | +$16.4M | 0.05% | 489 |
|
|
2022
Q3 | $15M | Buy |
60,925
+15,612
| +34% | +$4.76M | 0.02% | 760 |
|
|
2022
Q2 | $13.7M | Buy |
45,313
+14,434
| +47% | +$4.7M | 0.02% | 763 |
|
|
2022
Q1 | $12.7M | Sell |
30,879
-2,243
| -7% | -$878K | 0.02% | 809 |
|
|
2021
Q4 | $15.5M | Buy |
33,122
+13,908
| +72% | +$5.99M | 0.02% | 761 |
|
|
2021
Q3 | $8.16M | Sell |
19,214
-8,919
| -32% | -$3.76M | 0.01% | 1035 |
|
|
2021
Q2 | $10.1M | Buy |
28,133
+2,596
| +10% | +$858K | 0.01% | 930 |
|
|
2021
Q1 | $7.2M | Sell |
25,537
-18,034
| -41% | -$5.16M | 0.01% | 972 |
|
|
2020
Q4 | $12.3M | Buy |
43,571
+2,008
| +5% | +$563K | 0.02% | 702 |
|
|
2020
Q3 | $11.4M | Buy |
41,563
+10,629
| +34% | +$2.81M | 0.02% | 724 |
|
|
2020
Q2 | $7.03M | Sell |
30,934
-44,679
| -59% | -$8.78M | 0.01% | 873 |
|
|
2020
Q1 | $11.5M | Sell |
75,613
-8,029
| -10% | -$1.24M | 0.02% | 609 |
|
|
2019
Q4 | $12.6M | Buy |
83,642
+61,617
| +280% | +$8.97M | 0.02% | 712 |
|
|
2019
Q3 | $3.12M | Buy |
22,025
+9,001
| +69% | +$1.24M | 0.01% | 1282 |
|
|
2019
Q2 | $1.63M | Sell |
13,024
-20,731
| -61% | -$2.45M | ﹤0.01% | 1556 |
|
|
2019
Q1 | $3.72M | Buy |
33,755
+26,798
| +385% | +$2.79M | 0.01% | 1115 |
|
|
2018
Q4 | $682K | Sell |
6,957
-460
| -6% | -$49.9K | ﹤0.01% | 1708 |
|
|
2018
Q3 | $916K | Buy |
7,417
+1,000
| +16% | +$112K | ﹤0.01% | 1779 |
|
|
2018
Q2 | $637K | Buy |
6,417
+3,408
| +113% | +$314K | ﹤0.01% | 1912 |
|
|
2018
Q1 | $266K | Sell |
3,009
-12,210
| -80% | -$1.14M | ﹤0.01% | 2633 |
|
|
2017
Q4 | $1.5M | Sell |
15,219
-8,877
| -37% | -$870K | ﹤0.01% | 1676 |
|
|
2017
Q3 | $2.32M | Sell |
24,096
-4,946
| -17% | -$448K | 0.01% | 1068 |
|
|
2017
Q2 | $2.75M | Buy |
29,042
+12,833
| +79% | +$1.18M | 0.01% | 1021 |
|
|
2017
Q1 | $1.32M | Sell |
16,209
-5,064
| -24% | -$423K | ﹤0.01% | 1229 |
|
|
2016
Q4 | $1.8M | Buy |
21,273
+14,521
| +215% | +$1.14M | 0.01% | 998 |
|
|
2016
Q3 | $503K | Sell |
6,752
-22,226
| -77% | -$1.76M | ﹤0.01% | 1214 |
|
|
2016
Q2 | $2.2M | Buy |
28,978
+28,924
| +53,563% | +$2.1M | 0.01% | 821 |
|
|
2016
Q1 | $3.74K | Sell |
54
-11,574
| -100% | -$696K | ﹤0.01% | 2317 |
|
|
2015
Q4 | $700K | Sell |
11,628
-2,726
| -19% | -$164K | ﹤0.01% | 1228 |
|
|
2015
Q3 | $777K | Buy |
14,354
+8,369
| +140% | +$488K | ﹤0.01% | 1138 |
|
|
2015
Q2 | $348K | Buy |
5,985
+4,297
| +255% | +$240K | ﹤0.01% | 1473 |
|
|
2015
Q1 | $102K | Buy |
+1,688
| New | +$90K | ﹤0.01% | 1727 |
|
|
2014
Q4 | – | Sell |
-4,219
| Closed | -$189K | – | 3232 |
|
|
2014
Q3 | $189K | Buy |
4,219
+4,158
| +6,816% | +$177K | ﹤0.01% | 1894 |
|
|
2014
Q2 | $2.57K | Sell |
61
-501
| -89% | -$21.5K | ﹤0.01% | 2956 |
|
|
2014
Q1 | $24.4K | Sell |
562
-343
| -38% | -$16.1K | ﹤0.01% | 2219 |
|
|
2013
Q4 | $44.4K | Sell |
905
-18,353
| -95% | -$859K | ﹤0.01% | 1952 |
|
|
2013
Q3 | $792K | Sell |
19,258
-4,850
| -20% | -$185K | ﹤0.01% | 1254 |
|
|
2013
Q2 | $847K | Buy |
+24,108
| New | +$793K | ﹤0.01% | 1122 |
|
Other funds holding WST
VCM
VPM
GIM
BNP Paribas Financial Markets's WST Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its West Pharmaceutical (WST) stake by 18% in Q2 2026, selling an estimated $17.3M and leaving 257,112 shares worth $92.3M. The position accounts for 0.03% of the portfolio, ranked #479.
BNP Paribas Financial Markets first reported a position in WST in Q2 2013 and has held it in 52 quarters since. 679 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- BNP Paribas Financial Markets held 257,112 shares of West Pharmaceutical worth $92.3M as of Q2 2026.
- BNP Paribas Financial Markets sold 56,482 West Pharmaceutical shares in Q2 2026, an estimated $17.3M.
- West Pharmaceutical made up 0.03% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #479 holding.
- BNP Paribas Financial Markets first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
- 679 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.